Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
종목 코드 MOLN
회사 이름Molecular Partners AG
상장일Oct 22, 2014
CEODr. Patrick Amstutz, Ph.D.
직원 수159
유형Ordinary Share
회계 연도 종료Oct 22
주소Wagistrasse 14
도시SCHLIEREN
증권 거래소SIX Swiss Exchange
국가Switzerland
우편 번호8952
전화41447557700
웹사이트https://www.molecularpartners.com/
종목 코드 MOLN
상장일Oct 22, 2014
CEODr. Patrick Amstutz, Ph.D.
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음